TRLVNYSEMedicinal Chemicals & Botanical ProductsUS GAAP · USD

Trulieve Cannabis Corp.

Trulieve Cannabis Corp. is a vertically integrated cannabis company headquartered in Florida with operations across multiple U.S. states and listings in Canada and the United States. Its business combines cultivation, processing, manufacturing, wholesale distribution, and a large network of branded retail dispensaries serving medical and adult-use cannabis customers.

Revenue1,181m USD
−0.4 %y/y
Operating profit (EBIT)143m USD
+46.8 %y/y
EBIT margin12.1%
+3.9 ppy/y
Net income-122m USD
+23.9 %y/y
Free cash flow229m USD
+52.5 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-50005001,0001,500m USD2020: 522 m USD2020: EBIT 218 m USD20202021: 938 m USD2021: EBIT 197 m USD20212022: 1,218 m USD2022: EBIT 50 m USD20222023: 1,129 m USD2023: EBIT -222 m USD20232024: 1,186 m USD2024: EBIT 98 m USD20242025: 1,181 m USD2025: EBIT 143 m USD20251,181143
RevenueOperating profit (EBIT)

Business

Share of revenue
Retail cannabis sales65 %

Sales of cannabis products through Trulieve-branded dispensaries.

Wholesale and other revenue20 %

Sales to third-party channels and other non-retail revenue streams.

Cultivation and processing10 %

Internally produced cannabis flower and manufactured products supporting retail and wholesale.

Branded products and partner brands5 %

Proprietary brands and select partner-branded products sold in company stores and select markets.

Products

Reported · share of revenue
94.0%FY2025100 %
  • Retail94.0 %
  • Wholesale and Other6.0 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

Trulieve sells primarily to medical cannabis patients and adult-use consumers in the states where it operates licensed dispensaries. It also serves wholesale buyers and retail partners in select markets through branded and partner-branded product distribution. Customer demand is shaped by state-specific licensing, product availability, and the convenience of Trulieve’s store network.

Medical cannabis patients

Buy regulated cannabis products for condition-specific treatment in medical markets.

Adult-use consumers

Purchase cannabis products for recreational use in legalized adult-use states.

Retail dispensary shoppers

Visit Trulieve-branded stores for convenience, service, and product selection.

Wholesale and partner channels

Buy branded or partner-branded products for resale in select markets.

Strategy

Trulieve’s strategy centers on vertically integrated operations, branded retail, and a hub-based footprint in key state markets. The company emphasizes customer experience, product innovation, scaled production, and distribution network expansion to strengthen its position in regulated cannabis markets. It also uses data and technology platforms to support merchandising, promotions, compliance, and operating efficiency across production and retail.

Strengthen vertically integrated retail modelMedium term

Owning cultivation, processing, and stores helps control product quality and brand experience.

Defend and expand core state hubsMedium term

State licenses and local scale are key barriers to entry in cannabis.

Build brand portfolio and product breadthShort term

A wider range of price points and formats supports customer retention and basket growth.

Improve data-driven retail executionMedium term

Customer analytics support assortment, promotions, and outreach in a competitive market.

Geography

Trulieve operates in nine U.S. states, with its largest retail presence in Florida and meaningful operations in Arizona, Pennsylvania, West Virginia, Georgia, Ohio, Maryland, Connecticut, and Colorado. The company organizes its business into Southeast, Northeast, and Southwest hubs, with Florida, Pennsylvania, and Arizona serving as anchor markets. Geography matters because cannabis is licensed state by state, so store count, cultivation assets, and product access vary materially by market.

Risks

Trulieve faces regulatory risk because cannabis remains illegal under U.S. federal law even as state programs expand, which affects banking, marketing, and interstate operating flexibility. The business is also exposed to competition from multi-state operators, local operators, illicit-market sellers, and intoxicating hemp products, while agricultural, inventory, and impairment risks can affect operating performance and reported results.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Federal illegality of cannabis1State regulatory and licensing risk2Competitive pressure and price compression3Agricultural and cultivation risk4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Federal illegality of cannabisImpact: HighLikelihood: High

    U.S. federal law still restricts cannabis, affecting banking, tax, and interstate commerce.

    Exposure: All U.S. operations

  2. State regulatory and licensing riskImpact: HighLikelihood: Medium

    Operations depend on state licenses and changing rules for medical and adult-use markets.

    ExposureFloridaArizonaPennsylvaniaWest VirginiaOther states
  3. Competitive pressure and price compressionImpact: MediumLikelihood: Medium

    More licensed operators and illicit-market alternatives can pressure traffic and pricing.

    Exposure: Retail and wholesale cannabis sales

  4. Agricultural and cultivation riskImpact: MediumLikelihood: Low

    Cannabis is an agricultural product exposed to pests, disease, and production variability.

    Exposure: Cultivation and processing facilities

  5. Impairment of goodwill and long-lived assetsImpact: Medium

    Market declines or underperformance can trigger write-downs in a capital-intensive model.

    Exposure: Acquired businesses and facility assets

Accounting

Judgemental items
Inventory valuation

Cannabis inventory is valued at lower of cost or net realizable value using harvest and conversion assumptions.

Impact: Can change cost of goods sold and gross profit

Goodwill impairment

The company evaluates goodwill annually and on triggering events using market capitalization and outlook assumptions.

Impact: Can create large non-cash write-downs

Long-lived asset impairment

Cultivation and retail assets may be impaired if cash flows or market conditions deteriorate.

Impact: Affects operating income and asset values

Uncertain tax provisions

Cannabis tax and regulatory complexity can create judgment around tax liabilities.

Impact: Affects tax expense and balance sheet reserves

Seasonality

Sales vary around summer/winter patterns and promotional events such as 4/20 and Green Wednesday.

Impact: Quarterly comparability and revenue timing

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026